Highlights
- Revenue decreased by 5.3% from the previous financial year.
- Net loss expanded to AU$14.2 million.
- Shares have declined by 7.7% over the past week.
Universal Biosensors (ASX:UBI) has reported its full-year financial results for 2024, revealing a decline in revenue alongside an increase in net losses. The company recorded a revenue of AU$6.28 million, marking a 5.3% decrease from the fiscal year 2023.
The net loss for Universal Biosensors widened dramatically to AU$14.2 million, representing an increase of 111% compared to the previous year. Correspondingly, the loss per share has also deteriorated from AU$0.032 in FY 2023 to AU$0.053.
The earnings and revenue history for ASX:UBI as of February 27th, 2025, shows all figures are reflective of the trailing 12-month period. Following this financial update, Universal Biosensors' shares have seen a 7.7% drop over the past week.
Risk and Analysis
Investors should consider the risk analysis associated with Universal Biosensors, including several warning signs recently identified. Understanding these risks can provide a better perspective on the company's current standing and future potential.